Literature DB >> 36106264

Seronegative Immune-Mediated Necrotizing Myopathy: A Case Report.

Shriya Patel1, Mohammad Abu-Abaa2, Feryal Mousavi2.   

Abstract

Idiopathic inflammatory myopathies (IIMs) are a group of chronic autoimmune disorders characterized by proximal skeletal muscle weakness. One subtype of the IIMs is immune-mediated necrotizing myopathy (IMNM). IMNM can be further classified according to its autoantibody presence, including anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), anti-signal recognition particle (SRP), and seronegative.  Here, we describe the case of a 61-year-old Caucasian female with a prior history of distant lung cancer and current statin use presenting with a subacute onset of bilateral proximal lower extremity muscle weakness and markedly elevated creatinine kinase (CK) and amino transaminases. In the acute inpatient setting, she underwent successful treatment with corticosteroids that were eventually discontinued and replaced with azathioprine three months after hospital admission. At that point, she had attained a 60% increase in muscle strength.
Copyright © 2022, Patel et al.

Entities:  

Keywords:  corticosteroid treatment; immune-mediated necrotizing myopathy; inflammatory myositis; malignancy risk; statin use

Year:  2022        PMID: 36106264      PMCID: PMC9452053          DOI: 10.7759/cureus.27824

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  18 in total

1.  Intravenous Immune Globulin for Statin-Triggered Autoimmune Myopathy.

Authors:  Andrew L Mammen; Eleni Tiniakou
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

2.  Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis.

Authors:  Iago Pinal-Fernandez; Berta Ferrer-Fabregas; Ernesto Trallero-Araguas; Eva Balada; Maria Angeles Martínez; Jose César Milisenda; Gloria Aparicio-Español; Moises Labrador-Horrillo; Vicente Garcia-Patos; Josep M Grau-Junyent; Albert Selva-O'Callaghan
Journal:  Rheumatology (Oxford)       Date:  2018-02-01       Impact factor: 7.580

3.  More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.

Authors:  Eleni Tiniakou; Iago Pinal-Fernandez; Thomas E Lloyd; Jemima Albayda; Julie Paik; Jessie L Werner; Cassie A Parks; Livia Casciola-Rosen; Lisa Christopher-Stine; Andrew L Mammen
Journal:  Rheumatology (Oxford)       Date:  2017-05-01       Impact factor: 7.580

Review 4.  Paraneoplastic necrotizing myopathy: clinical and pathological features.

Authors:  M I Levin; T Mozaffar; M T Al-Lozi; A Pestronk
Journal:  Neurology       Date:  1998-03       Impact factor: 9.910

5.  Cancer and immune-mediated necrotizing myopathy: A longitudinal referral case-controlled outcomes evaluation.

Authors:  Shahar Shelly; Grayson Beecher; Margherita Milone; Teerin Liewluck; Floranne Ernste; James Triplett; Elie Naddaf; Anastasia Zekeridou; Andrew McKeon; Sean J Pittock; Divyanshu Dubey; John R Mills; Jay Mandrekar; Christopher J Klein
Journal:  Rheumatology (Oxford)       Date:  2022-03-14       Impact factor: 7.580

6.  Immune-mediated necrotizing myopathy associated with statins.

Authors:  Phyllis Grable-Esposito; Hans D Katzberg; Steven A Greenberg; Jayashri Srinivasan; Jonathan Katz; Anthony A Amato
Journal:  Muscle Nerve       Date:  2010-02       Impact factor: 3.217

Review 7.  Immune-Mediated Necrotizing Myopathy.

Authors:  Iago Pinal-Fernandez; Maria Casal-Dominguez; Andrew L Mammen
Journal:  Curr Rheumatol Rep       Date:  2018-03-26       Impact factor: 4.592

8.  Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.

Authors:  Iago Pinal-Fernandez; Cassie Parks; Jessie L Werner; Jemyma Albayda; Julie Paik; Sonye K Danoff; Livia Casciola-Rosen; Lisa Christopher-Stine; Andrew L Mammen
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-12-31       Impact factor: 4.794

Review 9.  Current Classification and Management of Inflammatory Myopathies.

Authors:  Jens Schmidt
Journal:  J Neuromuscul Dis       Date:  2018

10.  Autoantibody-Negative Immune-Mediated Necrotizing Myopathy Responds to Early and Aggressive Treatment: A Case Report.

Authors:  Dario A Marotta; Adena Zadourian; Maxwell J Jabaay; Ali Kesserwani; Hassan Kesserwani
Journal:  Cureus       Date:  2020-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.